What it's sold for

Anti-aging
Muscle & body composition
Sleep
Energy

What has actually been tested

Growth Hormone Deficiency
Abdominal Obesity
Aging
Obesity
HIV
HIV Infections
HIV Lipodystrophy
Lipodystrophy

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Not listed Anti-aging

Studied Muscle & body composition

Studied Sleep

Not listed Energy

Every trial on record

Every registered human study we can find for Sermorelin. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial ID	Title	Condition	Phase	Status	Enrolled
NCT07481734	Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)	Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis	Phase 2	Recruiting now	120
NCT06701071	Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation	Infertility, Female	Phase 4	Recruiting now	120
NCT06554717	Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV	HIV-1-infection, Frailty	Phase 2	Recruiting now	100
NCT01359488	VRS-317 in Adult Subjects With Growth Hormone Deficiency	Growth Hormone Deficiency	Phase 1	Completed	50
NCT00608023	TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy	Lipodystrophy, HIV Infections	Phase 3	Completed	263
NCT02553603	The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment	Mild Cognitive Impairment	Phase 1	Completed	22
NCT00675506	Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese	Abdominal Obesity, Growth Hormone Deficiency	Phase 2	Completed	60
NCT01264497	Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes	Type 2 Diabetes	Phase 2	Completed	55
NCT00850564	Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men	Healthy Volunteers	Not phased	Completed	15
NCT03018886	Diagnosing Adult Growth Hormone Deficiency	Growth Hormone Deficiency	Not phased	Completed	160
NCT01060488	Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency	Growth Hormone Deficiency	Phase 3	Completed	69
NCT00000380	Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances	Sleep Disorders	Not phased	Completed	—
NCT00257712	SMART: Somatotrophics, Memory, and Aging Research Trial	Aging, Mild Cognitive Impairment	Phase 2	Completed	151
NCT02012556	Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients	HIV	Phase 1	Completed	18
NCT03375788	Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk	Non-Alcoholic Fatty Liver Disease, Obesity	Phase 2	Completed	51
NCT00791843	The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure	Congestive Heart Failure	Phase 2	Completed	3
NCT00123253	TH9507 in Patients With HIV-Associated Lipodystrophy	HIV Infections, Lipodystrophy	Phase 3	Completed	412
NCT01263717	Effects of Growth Hormone Releasing Hormone in HIV	HIV, HIV Lipodystrophy	Not phased	Completed	54
NCT01701973	Effect of DPP4 Inhibition on Growth Hormone Secretion	Obesity	Phase 4	Completed	44
NCT02271282	Estradiol-Receptor Blockade in Older Men and Women	Normal Healthy Volunteers	Phase 1	Completed	40
NCT00795210	Effects of Short-term Growth Hormone in HIV-infected Patients	HIV Lipodystrophy	Not phased	Completed	25
NCT02196831	Tesamorelin Effects on Liver Fat and Histology in HIV	Human Immunodeficiency Virus (HIV), Nonalcoholic Fatty Liver Disease (NAFLD)	Not phased	Completed	61
NCT00324064	Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing	Growth Hormone Deficiency	Not phased	Completed	90
NCT03031535	Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers	Healthy Volunteer Study	Phase 1	Completed	32
NCT01897844	A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers	Healthy	Phase 1	Completed	36
NCT00448747	Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.	Diagnosis of Adult Growth Hormone Deficiency (AGDH)	Phase 3	Completed	101
NCT03226821	Body Composition and Adipose Tissue in HIV	HIV Lipodystrophy Syndrome, Growth Hormone Deficiency	Phase 4	Stopped early	6
NCT00720902	Adult Growth Hormone Deficiency and Cardiovascular Risk	Growth Hormone Deficiency	Phase 4	Stopped early	7
NCT01237041	Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children	Obesity, Short Stature	Phase 2	Stopped early	37
NCT02736591	Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response	Subfertility	Phase 3	Status not updated	210
NCT01632592	Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue	Abdominal Obesity	Not phased	Withdrawn before enrolling	0 — nobody enrolled
NCT00807365	Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly	Elderly	Phase 2	Stopped early	5
NCT01410799	Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly	Hormone Deficiency, Aging	Phase 2	Stopped early	13
NCT02931474	Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia	Sleep Disorder, Traumatic Brain Injury	Phase 2	Withdrawn before enrolling	0 — nobody enrolled

—Read this

A trial count is not a verdict

These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Common questions about Sermorelin

How many human trials does Sermorelin have?

34. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is Sermorelin FDA approved?

No. Sermorelin is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.

What is Sermorelin actually being tested for?

Registered studies cover: metabolic associated steatotic liver disease, nonalcoholic steatohepatitis, hepatic steatosis. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.